Joseph Newman

2.4k total citations · 1 hit paper
55 papers, 1.0k citations indexed

About

Joseph Newman is a scholar working on Molecular Biology, Molecular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Joseph Newman has authored 55 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 13 papers in Molecular Medicine and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Joseph Newman's work include Antibiotic Resistance in Bacteria (13 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers) and Cancer therapeutics and mechanisms (8 papers). Joseph Newman is often cited by papers focused on Antibiotic Resistance in Bacteria (13 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers) and Cancer therapeutics and mechanisms (8 papers). Joseph Newman collaborates with scholars based in United States, United Kingdom and Russia. Joseph Newman's co-authors include David B. Schauer, Takeo Kosaka, Barbara J. Sheppard, James G. Fox, A G Vallon, A S Mee, Sharda Jha, Brian A. Zabel, Larry Tsai and Jian Zhou and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Joseph Newman

50 papers receiving 978 citations

Hit Papers

Respiratory sequelae of COVID-19: pulmonary and extrapulm... 2023 2026 2024 2025 2023 25 50 75
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Respiratory sequelae of COVID-19: pulmonary and extrapulmonary origins, and approaches to clinical care and rehabilitation
    2023 80 citations Sally Singh, Molly M Baldwin et al. The Lancet Respiratory Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph Newman United States 17 401 198 184 154 129 55 1.0k
Soichiro Kimura Japan 18 312 0.8× 161 0.8× 200 1.1× 191 1.2× 173 1.3× 46 808
Brooke A. Napier United States 17 650 1.6× 306 1.5× 135 0.7× 160 1.0× 173 1.3× 23 1.2k
Ji Zeng China 15 381 1.0× 263 1.3× 155 0.8× 124 0.8× 200 1.6× 30 1.1k
Ilaria Frasson Italy 22 919 2.3× 263 1.3× 134 0.7× 138 0.9× 313 2.4× 37 1.5k
Ni Tien Taiwan 22 343 0.9× 138 0.7× 315 1.7× 80 0.5× 242 1.9× 71 1.2k
Hamidreza Houri Iran 15 325 0.8× 180 0.9× 181 1.0× 98 0.6× 171 1.3× 66 808
Tiffany R. Keepers United States 14 198 0.5× 264 1.3× 412 2.2× 248 1.6× 233 1.8× 20 1.1k
Shuying Li China 18 246 0.6× 285 1.4× 155 0.8× 146 0.9× 251 1.9× 56 1.1k
Paul Miller United States 9 960 2.4× 131 0.7× 317 1.7× 70 0.5× 166 1.3× 15 1.7k
Ayşegül Yağcı Türkiye 15 545 1.4× 148 0.7× 391 2.1× 143 0.9× 243 1.9× 46 1.1k

Countries citing papers authored by Joseph Newman

Since Specialization
Citations

This map shows the geographic impact of Joseph Newman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Newman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Newman more than expected).

Fields of papers citing papers by Joseph Newman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Newman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Newman. The network helps show where Joseph Newman may publish in the future.

Co-authorship network of co-authors of Joseph Newman

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Newman. A scholar is included among the top collaborators of Joseph Newman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Newman. Joseph Newman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Newman, Joseph, Hakim Ghani, G. Fischer, et al.. (2025). The Pulmonary Hypertension Global Patient Survey: understanding the experiences and perspectives of patients. ERJ Open Research. 11(6). 297–2025.
2.
Newman, Joseph, Luke Flower, R. Jones, et al.. (2025). Longer term post-hospital morbidity and mortality following admission with COVID-19: a systematic review and meta-analysis. ERJ Open Research. 11(5). 1281–2024.
3.
Mizrahi, Jonathan, William Senapedis, Colm P. O’Donnell, et al.. (2025). First-in-human phase 1/2 study (MYCHELANGELO I) of first-in-class epigenomic controller OTX-2002 targeting MYC oncogene in patients with hepatocellular carcinoma (HCC) and other solid tumors.. Journal of Clinical Oncology. 43(4_suppl). 606–606. 2 indexed citations
4.
Newman, Joseph, Gregg H. Rawlings, David G. Kiely, et al.. (2025). Selection of patient-reported outcome measures in pulmonary arterial hypertension clinical trials: a systematic review, meta-analysis and health-related quality of life framework. European Respiratory Review. 34(176). 250006–250006.
5.
Newman, Joseph, Philipp S. Wild, Charlotte Summers, & Mark Toshner. (2024). Associate Principal Investigators and the HEAL-COVID trial: good for trainees, good for trials. Trials. 25(1). 90–90. 1 indexed citations
6.
7.
Sylvester, Karl, et al.. (2024). Shorter walk test durations to detect ambulatory oxygen desaturation in interstitial lung disease: an observational cohort study. ERJ Open Research. 11(3). 891–2024. 1 indexed citations
8.
Newman, Joseph, et al.. (2023). Pulmonary Hypertension International Survey of Health Impacts (PHISH): a global patient questionnaire. PA3503–PA3503. 1 indexed citations
9.
Singh, Sally, Molly M Baldwin, Enya Daynes, et al.. (2023). Respiratory sequelae of COVID-19: pulmonary and extrapulmonary origins, and approaches to clinical care and rehabilitation. The Lancet Respiratory Medicine. 11(8). 709–725. 80 indexed citations breakdown →
10.
Newman, Joseph, David P. Jenkins, Choo Ng, et al.. (2021). Rising COVID-19 related acute pulmonary emboli but falling national chronic thromboembolic pulmonary hypertension referrals from a large national dataset. ERJ Open Research. 7(4). 431–2021. 9 indexed citations
11.
Newman, Joseph, et al.. (2021). Loperamide: an emerging drug of abuse and cause of prolonged QTc. Clinical Medicine. 21(2). 150–152. 8 indexed citations
12.
Newman, Joseph, et al.. (2019). Medical students on the hospital ward: what do patients really think?. Future Healthcare Journal. 6(Suppl 1). s169–s169. 2 indexed citations
13.
Liu, Mingyu, Sarah M. McLeod, John Wiseman, et al.. (2014). Secreted Gaussia princeps Luciferase as a Reporter of Escherichia coli Replication in a Mouse Tissue Cage Model of Infection. PLoS ONE. 9(3). e90382–e90382. 9 indexed citations
14.
Kawatkar, Sameer, Thomas A. Keating, N.B. Olivier, et al.. (2014). Antibacterial Inhibitors of Gram-Positive Thymidylate Kinase: Structure–Activity Relationships and Chiral Preference of a New Hydrophobic Binding Region. Journal of Medicinal Chemistry. 57(11). 4584–4597. 49 indexed citations
15.
Mills, Scott D., Ann E. Eakin, Ed T. Buurman, et al.. (2010). Novel Bacterial NAD + -Dependent DNA Ligase Inhibitors with Broad-Spectrum Activity and Antibacterial Efficacy In Vivo. Antimicrobial Agents and Chemotherapy. 55(3). 1088–1096. 63 indexed citations
16.
Schmalstieg, Dieter, Gerhard Schall, Daniel Wägner, et al.. (2007). Managing Complex Augmented Reality Models. IEEE Computer Graphics and Applications. 27(4). 48–57. 28 indexed citations
17.
Newman, Joseph, et al.. (2003). A path from primary protein sequence to ligand recognition. Proteins Structure Function and Bioinformatics. 50(4). 589–599. 12 indexed citations
18.
Newman, Joseph, Takeo Kosaka, Barbara J. Sheppard, James G. Fox, & David B. Schauer. (2001). Bacterial Infection Promotes Colon Tumorigenesis in Apc Min/+ Mice. The Journal of Infectious Diseases. 184(2). 227–230. 117 indexed citations
19.
Mansfield, Keith G., Joseph Newman, David B. Schauer, et al.. (2001). EnteropathogenicEscherichia coliand Ulcerative Colitis in Cotton‐Top Tamarins(Saguinus oedipus). The Journal of Infectious Diseases. 184(6). 803–807. 31 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Soichiro Kimura Breakdown of academic impact, for papers by Brooke A. Napier Breakdown of academic impact, for papers by Ji Zeng Breakdown of academic impact, for papers by Ilaria Frasson Breakdown of academic impact, for papers by Ni Tien Breakdown of academic impact, for papers by Hamidreza Houri Breakdown of academic impact, for papers by Tiffany R. Keepers Breakdown of academic impact, for papers by Shuying Li Breakdown of academic impact, for papers by Paul Miller Breakdown of academic impact, for papers by Ayşegül Yağcı
Rankless by CCL
2026